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Summary
Background: Vertebrate oocytes are arrested in meta-
phase II of meiosis prior to fertilization by cytostatic fac-
tor (CSF). CSF enforces a cell-cycle arrest by inhibiting
the anaphase-promoting complex (APC), an E3 ubiquitin
ligase that targets Cyclin B for degradation. Although
Cyclin B synthesis is ongoing during CSF arrest, con-
stant Cyclin B levels are maintained. To achieve this, oo-
cytes allow continuous slow Cyclin B degradation, with-
out eliminating the bulk of Cyclin B, which would induce
release from CSF arrest. However, the mechanism that
controls this continuous degradation is not understood.
Results: We report here the molecular details of a nega-
tive feedback loop wherein Cyclin B promotes its own
destruction through Cdc2/Cyclin B-mediated phos-
phorylation and inhibition of the APC inhibitor Emi2.
Emi2 bound to the core APC, and this binding was dis-
rupted by Cdc2/Cyclin B, without affecting Emi2 protein
stability. Cdc2-mediated phosphorylation of Emi2 was
antagonized by PP2A, which could bind to Emi2 and
promote Emi2-APC interactions.
Conclusions: Constant Cyclin B levels are maintained
during a CSF arrest through the regulation of Emi2 activ-
ity. A balance between Cdc2 and PP2A controls Emi2
phosphorylation, which in turn controls the ability of
Emi2 to bind to and inhibit the APC. This balance allows
proper maintenance of Cyclin B levels and Cdc2 kinase
activity during CSF arrest.
*Correspondence: kornb001@mc.duke.eduIntroduction
Vertebrate oocytes remain arrested for prolonged pe-
riods in metaphase II of meiosis through the action of
cytostatic factor (CSF), an activity defined on the basis
of the ability of injected cytoplasm from unfertilized
Xenopus eggs to block blastomere cleavage [1]. Fertil-
ization triggers release from this arrest, promoting entry
into the early embryonic cell cycles. The nature of CSF
has not been fully defined, but Mos, the apical kinase
in a MAPK cascade, is critical to the establishment of
the CSF arrest [2–6]. Cdk2/Cyclin E has also been impli-
cated as a CSF component [7].
A defining feature of the CSF arrest is maintenance of
high Cdc2/Cyclin B activity. CSF inhibits the APC, an E3
ubiquitin ligase that promotes destruction of Cyclin B
and other proteins whose degradation is important for
M phase exit. Cdc20 or Cdh1 promotes APC activation,
depending upon the precise cell-cycle stage [8–10].
CSF-arrest establishment has been reported to rely on
factors that enforce APC inhibition by the spindle assem-
bly checkpoint (e.g., Mad2) [11, 12]. However, Mad2 is
not necessary for maintaining the CSF arrest, suggesting
that CSF might rely upon factors other than spindle-
checkpoint components to maintain APC inhibition [13].
Previously, it was reported that a protein known as
Emi1 could bind Cdc20 to inhibit the APC [14]. Immuno-
depletion of Emi1 from CSF-arrested Xenopus egg
extracts promoted release from CSF arrest. Moreover,
recombinant Emi1 promoted a CSF-like arrest in egg
extracts. Despite its ability to inhibit the APC, the impor-
tance of Emi1 in the CSF arrest was called into question
by observations suggesting that Emi1 was present at
insufficient levels in CSF-arrested eggs and extracts to
be responsible for the arrest [15]. Moreover, Emi1 stabi-
lized both A type and B type cyclins, whereas the endog-
enous arrest promoted stabilization of only Cyclin B [16].
Recently, an Emi1-related protein, Emi2, has been impli-
cated in the CSF arrest. This APC inhibitor, which also
contains a putative Cdc20 binding domain, can promote
a CSF-like arrest and is sufficiently abundant in CSF
extracts to potentially contribute to the arrest. Moreover,
its depletion resulted in spontaneous APC activation and
release from the CSF arrest [17, 18]. Importantly, the
free-intracellular-calcium increase that accompanies
fertilization and triggers release from the CSF arrest
leads to Emi2 degradation, thereby alleviating APC inhi-
bition and promoting CSF release [19, 20]. Thus, it seems
likely that Emi2, inadvertently depleted by antibodies
prepared against Emi1, is the more important mediator
of the CSF arrest.
Calcium-induced Emi2 degradation is triggered by the
CaMKII-mediated phosphorylation of Emi2 at Thr 195 (of
Xenopus Emi2) [20, 21], providing a docking site for the
Polo-like kinase, Plx1, whose phosphorylation of Emi2
creates a phosphodegron recognized by the b-TrCP
E3 ubiquitin ligase. Together, CaMKII and Plx1 promote
Emi2 degradation.
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214Although Cyclin B degradation occurs primarily at exit
from CSF arrest (and with each subsequent M phase
exit), there is evidence to suggest that Cyclin B degrada-
tion occurs at continuous low levels during a CSF arrest
to counterbalance ongoing Cyclin B synthesis [22, 23].
Without this, Cyclin B levels would rise unabated
throughout the arrest, resulting in a gradual, rather than
a precipitous, exit from the CSF arrest upon fertilization
(due to the presence of a large bolus of Cyclin B to de-
grade). This ongoing Cyclin B degradation appears to
be triggered by Cdc2/Cyclin B kinase activity itself,
such that Cyclin B synthesis leads to higher Cdc2 kinase
activity and results in compensatory Cyclin B degrada-
tion [24]. Although this regulatory loop has been well-
documented, the molecular mechanisms linking Cdc2/
Cyclin B kinase activity and APC activation during a CSF
arrest have not been reported. We show here that Emi2 is
phosphorylated and inhibited by Cdc2/Cyclin B at sites
distinct from the CaMKII/Plx1 sites, though Cdc2 phos-
phorylation does not promote Emi2 degradation. Rather,
Emi2 can bind and inhibit the full APC (rather than Cdc20
alone) and Emi2-APC interactions are inhibited by Cdc2
phosphorylation of Emi2. Thus, Cdc2-mediated Emi2
phosphorylation relieves APC inhibition, allowing Cyclin
B degradation. In addition, Cdc20s effects on Emi2 are
antagonized by PP2A-mediated Emi2 dephosphoryla-
tion, which facilitates the Emi2-APC interaction. These
findings establish an auto-regulatory loop comprised of
Cdc2/Cyclin B, PP2A, Emi2, and the APC that controls
Cyclin B levels to properly maintain the CSF arrest and
allow for rapid M phase exit upon fertilization.
Results
Cdc2/Cyclin B Targets Emi2 to Regulate Cyclin B
As reported by Kishimoto and colleagues [24], Cyclin B
synthesis continues during a cytostatic factor (CSF)
arrest, a finding we have repeated with similar results
(Figure 1A, top). Continued protein synthesis would be
expected to result in a steady increase in Cyclin B levels
during a CSF arrest, but this steady increase is not ob-
served. Rather, we observe constant levels of Cyclin B
throughout CSF arrest (Figure 1A, bottom). Thus, for
maintaining constant Cdc2/Cyclin B activity during the
arrest, a continual low level of Cyclin B degradation is
required, as demonstrated by the degradation of radio-
labeled Cyclin B in a CSF-arrested extract (Figure 1B,
left). This degradation is prevented by the proteasome
inhibitor MG132 (Figure 1B, right). Additionally, immuno-
depletion of the APC using Cdc27 antibodies resulted
in a gradual increase in Cyclin B, accompanied by in-
creased Cyclin B/Cdc2 kinase activity (Figures 1C and
1D). We note that Histone H1 kinase activity eventually
plateaued, even in the absence of the APC. This raises
the interesting possibility that Cdc2/Cyclin B1 kinase
activity not only might promote Cyclin B degradation,
but might also limit its translation. Confirming previously
reported results, we also found that addition of excess
Cyclin B to CSF extracts to activate latent Cdc2 en-
hanced APC-mediated Cyclin B degradation, consistent
with a role for Cdc2/Cyclin B activity in triggering Cyclin
B destruction (Figure 1E). Moreover, Cdc2/Cyclin B ki-
nase activity increased only transiently upon addition
of recombinant Cyclin B, consistent with the inductionof compensatory degradation (Figure 1F). As shown in
Figure 1G, Cyclin B addition also induced the degrada-
tion of another APC substrate (Securin) in a dose-depen-
dent manner.
With the discovery that Emi2 protein plays a key role
in maintaining CSF arrest, we hypothesized that Cdc2/
Cyclin B might control its own degradation by modulat-
ing Emi2 function. CaMKII-mediated phosphorylation of
Emi2 at fertilization promotes Emi2 degradation, reliev-
ing APC inhibition. However, Cdc2/Cyclin B-induced
Cyclin B degradation was not inhibited by CaMKII inhib-
itors at concentrations that prevented Ca2+-induced Cy-
clin B degradation (Figure 1H, [25]). Moreover, addition
of 40 nM Cyclin B to extracts did not promote Emi2 de-
struction (Figure 1I); similar results were obtained when
80 nM Cyclin B was added, although some Emi2 degra-
dation could be observed at later time points, consistent
with previous reports that very high Cdc2 kinase activity
induces Emi2 degradation [21]. Therefore, we have re-
stricted our use of recombinant Cyclin B1 to levels that
do not induce Emi2 degradation. Interestingly, adding
excess Emi2 to CSF extracts blocked acceleration of
Cyclin B degradation by exogenous Cyclin B protein
(Figure 1J). In that excess Emi2 could circumvent the
ability of Cdc2/Cyclin B to increase Cyclin B degrada-
tion, these data suggested that Cdc2/Cyclin B might
control Cyclin B levels by antagonizing Emi2.
Cdc2/Cyclin B Disrupts the Association
of Emi2 and APC/Cdc20
Consistent with the hypothesis that Cdc2/Cyclin B could
modulate Emi2, we found that Cdc2 could phosphorylate
Emi2 in vitro (Figure 2A). To determine whether there
were consequences of this phosphorylation, we ana-
lyzed Emi2-APC interactions. The Emi2 relative, Emi1,
interacts with the APC activator Cdc20 to disrupt APC-
Cdc20 interactions [26]. In examining Emi2-APC interac-
tions, we found that Emi2 could coprecipitate with the
APC-core component Cdc27 (Figure 2B). To see whether
Cdc20 was required for this interaction, we generated
a Cdc20-depleted extract and found that Emi2 could still
coprecipitate with Cdc27, even in an egg extract immu-
nodepleted of w80% of Cdc20 (Figure 2C). Consistent
with this, Emi2 was detected in Cdc27 immunoprecipi-
tates, but was absent from Cdc20 immunoprecipitates
(Figure 2D). We next separated CSF extracts on 5%–
30% sucrose gradients and identified APC-containing
fractions by immunoblotting for Cdc27 and APC2 (frac-
tions 14–18; Figure 2E and data not shown). That the
Cdc27 coprecipitation reflected a true interaction of
Emi2 with the APC is suggested by the fact that a portion
of Emi2 cosedimented with the intact APC (Emi2 anti-
body recognizes three bands, as discussed in Figure 2H).
Although high levels of GST-Emi2 associated with and
precipitated small amounts of Cdc20 from extracts
even after APC immunodepletion (data not shown), we
could not detect independent interaction between
Emi2 and Cdc20 when Cdc20 was immunoprecipitated
from gradient fractions (6 and 7) containing both Emi2
and Cdc20, but lacking other APC components (Fig-
ure 2F, left). In contrast, Emi2 was detected in anti-
Cdc20 immunoprecipitates formed from gradient frac-
tions containing the full APC (fractions 15 and 16),
although there was considerably less Emi2 present
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215Figure 1. Emi2 Antagonizes Cdc2/Cyclin B-Induced Degradation of Cyclin B
(A) (Top) CSF-arrested Xenopus egg extracts were incubated in the presence of 35S-labeled methionine and cysteine. At the indicated times,
endogenous Cyclin B2 protein was immunoprecipitated and newly synthesized Cyclin B2 was detected by autoradiography. (Bottom) Total
Cyclin B2 levels were measured in a CSF extract at the indicated times by immunoblotting.
(B) (Top) 35S-labeled Cyclin B1 was added into CSF extracts in the absence (2, left) or the presence (+, right) of MG132 (100 mM). Aliquots were
withdrawn at the indicated times, and the amount of Cyclin B1 was detected by autoradiography. (Bottom) The radiolabeled Cyclin B1 remaining
at each time point was quantified. Error bars represent standard deviation of four measurements.
(C) (Top) The APC was depleted from CSF extracts with three sequential incubations with IgG or Cdc27 antibodies. Samples from each extract
were resolved by SDS-PAGE and immunoblotted with Cdc27 antibodies. (Bottom) Samples were taken from control or APC (Cdc27)-depleted
extracts at the indicated times after incubation with energy-regenerating mix at room temperature. The amount of Cyclin B2 was examined by
immunoblotting (10 mg total protein was loaded per lane to clearly visualize the changes in endogenous Cyclin B levels).
(D) (Top) The APC was depleted from CSF extracts as described in (C). (Bottom) After 30 min incubation at room temperature, the Cdc2/Cyclin B
kinase activity in control or APC (Cdc27)-depleted extracts was measured at the indicated times by using Histone H1 kinase assays. The phos-
phorylation of Histone H1 was quantified, normalized, and plotted.
(E) Buffer (control), GST, or 40 nM Cyclin B1 was added to CSF extracts. At the indicated times, samples were withdrawn and endogenous Cyclin
B2 levels were measured by immunoblotting.
(F) At the indicated times, Cdc2/Cyclin B kinase activity in the CSF extracts was measured in the presence or absence of recombinant Cyclin B1
(40 nM) by using Histone H1 as an exogenous substrate. The phosphorylation of Histone H1 was quantitated, normalized, and plotted.
(G) Buffer (control) or Cyclin B1 (40 nM or 80 nM) was added to CSF extracts. At the indicated times, samples were withdrawn and Securin levels
were measured by immunoblotting.
(H) Ca2+ or recombinant Cyclin B1 was added into CSF extracts in the presence or absence of the CaMKII peptide inhibitor (281–309, 400 mM).
Samples were taken at the indicated times, and the amount of endogenous Cyclin B2 was measured by immunoblotting.
(I) Radiolabeled Emi2 was added into CSF extracts supplemented with 40 nM recombinant Cyclin B1. The levels of Emi2 in the extract were
examined at the indicated times by autoradiography.
(J) Cyclin B1 was added into CSF extracts in the presence of GST or GST-Emi2. At the indicated times, samples were taken and the amount of
endogenous Cyclin B2 was determined by immunoblotting.
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216Figure 2. Cdc2/Cyclin B Disrupts the Association of Emi2 and APC/Cdc20
(A) Histone H1 (left) or in vitro-translated Emi2 (right) was mixed with [g-32P] ATP in the presence or absence of recombinant Cdc2/Cyclin B kinase
at room temperature for 10 min. The reactions were separated by SDS-PAGE, and the phosphorylation of Histone H1 or Emi2 was monitored by
autoradiography.
(B) GST or GST-Emi2 proteins bound to glutathione-Sepharose beads were incubated in CSF extracts. After incubation, the protein beads were
pelleted, washed, and immunoblotted for the APC-core component, Cdc27.
(C) (Left) CSF extracts were depleted of Cdc20 by two consecutive incubations with Cdc20 antibody. The mock (IgG)- and Cdc20-depleted ex-
tracts were resolved by SDS-PAGE and immunoblotted with Cdc20 antibodies. (Right) GST-Emi2 linked to glutathione Sepharose was incubated
in control or Cdc20-depleted extracts, retrieved, washed, and immunoblotted for Cdc27.
(D) Control IgG, Cdc27 (left), or Cdc20 (right) antibodies were immobilized on Protein A Sepharose beads and incubated in CSF extracts. The
beads were retrieved, washed, and immunoblotted for Emi2.
(E) CSF extracts was fractionated on a 5%–30% sucrose gradient. Fractions were collected, analyzed by SDS-PAGE, and immunoblotted for
Cdc27, Cdc20, and Emi2. The open arrow and bar indicate the APC complex.
(F) Cdc20 (left) or Cdc27 (right) antibodies were immobilized on Protein A Sepharose beads and incubated in sucrose-gradient fractions 6 and 7
(pooled) or 15 and 16 (pooled). After incubation, the beads were retrieved by centrifugation, washed, and immunoblotted for Emi2.
(G) Cdc27 antibody was used to deplete CSF extract of the APC. IgG- or Cdc27-depleted extracts were immunoblotted for Cdc27 (left) or Emi2
(right).
(H) Emi2 antibodies immobilized on Protein A Sepharose beads were incubated in CSF extracts. After incubation, the beads were retrieved,
washed, and incubated in the presence (+) or the absence (2) of l phosphatase before being resolved by SDS-PAGE and immunoblotting for
Emi2.
(I) GST-Emi2 linked to glutathione Sepharose was incubated in CSF extracts in the presence or absence of 80 nM recombinant Cyclin B1 pro-
teins. After incubation, the protein beads were retrieved by centrifugation, washed, and immunoblotted for Cdc27 or GST.
(J) (Left) Cdc2/Cyclin B kinase activity was measured in CSF extracts in the presence or absence of exogenous recombinant Cyclin B1 (10 nM) by
using Histone H1 as an exogenous substrate. The phosphorylation of Histone H1 was quantitated and plotted. Error bars represent standard
deviation of three measurements. (Right) Cdc27 antibodies were immobilized on Protein A Sepharose beads and incubated in CSF extracts
in the presence or absence of Cyclin B1 (10 nM). The beads were retrieved, washed, and immunoblotted for Emi2 or Cdc27.
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217(Figure 2F, left). Emi2 also coimmunoprecipitated with
Cdc27 in the fractions containing the full APC (fractions
15 and 16; Figure 2F, right). Given that Cdc20 did not
bind Emi2 in the monomeric Cdc20 fractions (6 and 7)
or in CSF extract (Figure 2D, left), Emi2-Cdc20 interac-
tions in the higher-molecular-weight fractions may be
mediated by the core APC (which binds both Emi2 and
Cdc20). These data suggest that Emi2 associates more
strongly with the full APC than with Cdc20 alone and
that Cdc20, Emi2, and the core APC cosediment and co-
precipitate, indicating that Emi2 is not likely to inhibit the
APC by preventing APC-Cdc20 interactions. Moreover,
the majority of Emi2 was codepleted from CSF extracts
when Cdc27 was immunodepleted (Figure 2G). These
data suggest that the bulk of Emi2 in extracts is APC as-
sociated. Emi2 antibody recognizes more than one band
on SDS-PAGE; phosphatase treatment of Emi2 immuno-
precipitates indicates that some of this complexity arises
from phosphorylated Emi2 species (Figure 2H).
To determine how Cdc2 might affect Emi2-APC inter-
actions, we treated CSF extracts with excess Cyclin B
and added GST-Emi2. As shown in Figure 2I, elevating
Cyclin B levels interfered with the ability of GST-Emi2
to precipitate the APC (detected by Cdc27 immunoblot-
ting). Moreover, excess Cyclin B prevented precipitation
of Emi2 with the APC from the high-molecular-weight
gradient fractions (fractions 15 and 16; data not shown).
At lower levels of Cyclin B addition (10 nM), resulting
in slight elevations in Cdc2 kinase activity (Figure 2J,
left), we also observed loss of Emi2 from Cdc27 immu-
noprecipitates, suggesting that even small increases in
Cyclin B promote some Emi2 dissociation from the
APC (Figure 2J, right). These observations suggested
that Cdc2/Cyclin B might dissociate the Emi2-APC com-
plex, allowing compensatory Cyclin B degradation when
Cyclin B levels rise during a CSF arrest.
Cdc2/Cyclin B Disrupts Interactions between
the C-Terminal Region of Emi2 and the APC
Because it has been reported that a C-terminal fragment
of Emi2 containing the zinc-binding region (ZBR, aa 583–
624) could rescue the Emi2-depletion-induced release
from CSF arrest [17], we suspected that APC binding
might reside within this region of Emi2. To confirm this,
we assayed the ability of GST-fused protein fragments
spanning the length of Emi2 to precipitate the APC-
core component Cdc27. Only the Emi2 fragment con-
taining amino acids 489 to 651 could precipitate Emi2
(Figure 3A). Moreover, Emi2 protein lacking only this
fragment (aa 1–488) was unable to bind the APC (Fig-
ure 3A). In addition, the 489–651 Emi2 fragment was
sufficient to prevent Cyclin B degradation and Ca+2-me-
diated release from the CSF arrest (Figure 3B). Surpris-
ingly, Emi2’s N-terminal fragment (aa 1–488) that could
not bind the APC also inhibited Ca2+-induced Cyclin B
degradation (Figure 3C). However, because the N termi-
nus contains sites of CaMKII (T195) and Plx1 phosphor-
ylation (S33/38), we hypothesized that expression of
the 1–488 fragment might inhibit degradation of endog-
enous Emi2 by competing for these kinases [19]. As
shown in Figure 3D, this was the case, suggesting that
the ability of the 1–488 fragment to inhibit Cyclin B deg-
radation was mediated by endogenous full-length Emi2,
whose degradation was inhibited by excess 1–488fragment. To determine whether Cdc2/Cyclin B targeted
the region of Emi2 contained within the 489–651 frag-
ment to disrupt its interactions with the APC, we re-
peated binding assays between GST-Emi2 (aa 489–651)
and Cdc27 in CSF extracts supplemented with excess
Cyclin B. High levels of Cyclin B disrupted interactions
between the C terminus of Emi2 (aa 489–651) and the
APC (Figure 3E). Moreover, Cdc2 kinase activity was
required for this dissociation because the Cdk inhibitor
roscovitine restored the interaction between Emi2 and
APC even in the presence of high Cyclin B levels (Fig-
ure 3E). Similarly, depleting Cdc2 from extracts by using
p13-Sepharose restored Emi2-APC interactions (data
not shown). To demonstrate that Cdc2/Cyclin B-in-
duced modification of the Emi2 C terminus could alter
its APC-inhibitory properties, we showed that the Emi2
C terminus could inhibit the APC in vitro as well as full-
length Emi2 (Figure 3F, lanes 3 and 6). We then immobi-
lized the GST-Emi2 C terminus on glutathione Sephar-
ose, dipped this protein into CSF extract or extract
treated with excess Cyclin B protein, and retrieved the
Emi2 protein by centrifugation. The ‘‘dipped’’ Emi2
was then eluted from the Sepharose with free glutathi-
one and added to an in vitro APC assay. As shown in
Figure 3F (lanes 4–7, see also Figure 4I), whereas the
GST-Emi2 C terminus dipped into control extract could
retard APC-mediated ubiquitination of Cyclin B protein
in vitro, the same protein exposed to Cyclin B-treated
CSF extracts lost its APC-inhibitory activity. Collec-
tively, these data suggest that the Emi2 C terminus is a
downstream target of Cdc2/Cyclin B in regulating the
APC and raise the possibility that phosphorylation of
the Emi2 C terminus by Cdc2 might interfere with its
APC binding and inhibition.
Phosphorylation of Emi2 by Cdc2 at T545 and T551
Disrupts APC Binding and Inhibition
In order to identify the sites of Cdc2-mediated Emi2
phosphorylation, we incubated the GST-Emi2 C termi-
nus in CSF extract in the presence or absence of excess
Cyclin B and, following in-gel trypsin digestion, sub-
jected the Emi2 proteins to liquid chromatography/
mass spectrometry (LC/MS) analysis. Cdc2 phosphory-
lation sites were found within a 12 mer peptide contain-
ing T545 and T551 (Figure 4A). In the absence of Cyclin
B, no phosphorylation on the same peptide was de-
tected by LC/MS analysis at the expected LC retention
time (data not shown). To determine whether these sites
were important for the ability of Cdc2/Cyclin B to disrupt
Emi2-APC interactions, we mutated T545 and T551 to
the nonphosphorylatable Ala, either singly or in combi-
nation. We performed LC/MS again with GST-Emi2
(aa 489–651) T545/551A proteins. Neither mono- nor
diphosphorylated peptide (residues 545–556) was de-
tected in extracted-ion-chromatography analysis (Fig-
ure 4B). Moreover, mutation of either T545 or T551 to
Ala somewhat diminished phosphorylation of Emi2 in
CSF extracts supplemented with excess Cyclin B, but
mutation of these sites together largely abrogated phos-
phorylation (data not shown and Figure 4C). Depletion of
Cdc2 from CSF extracts prior to addition of excess Cy-
clin B greatly diminished Emi2 (aa 489–651) phosphor-
ylation (Figure 4D). Finally, phosphorylation of Emi2 by
Cdc2/Cyclin B in vitro was abrogated by mutation of
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(A) GST-Emi2 protein fragments bound to glutathione Sepharose were incubated in CSF extracts, retrieved, washed, and immunoblotted for
Cdc27 or GST.
(B) GST or GST-Emi2 proteins (full-length [FL] or C-terminal [aa 489–651]) were added into CSF extracts supplemented with Ca2+. Aliquots
removed at the indicated times were analyzed by SDS-PAGE and immunoblotted for Cyclin B2.
(C) Emi2 full-length (FL), N-terminal (aa 1–488), or C–terminal (aa 489–651) GST proteins were added into CSF extracts supplemented with Ca2+.
Aliquots were removed at the indicated times and immunoblotted for Cyclin B2.
(D) (Top) 35S-labeled Emi2 was added to CSF extracts supplemented with GST or the indicated GST-Emi2 proteins. After Ca2+ addition, aliquots
were removed at the indicated times, and the amount of 35S-labeled Emi2 was examined by autoradiography. (Bottom) The amount of
35S-labeled Emi2 at each time point was quantified, normalized, and plotted. Error bars represent standard deviation of three replicates.
(E) GST-Emi2 (aa 489–651) (4 mM) was incubated in CSF extracts in the presence or absence of 80 nM recombinant Cyclin B1 with or without the
Cdc2 kinase inhibitor roscovitine (ROS, 100 mM). GST-Emi2 was retrieved from the extracts by centrifugation, washed, and immunoblotted for
Cdc27 or GST.
(F) (Top) GST-Emi2 FL (lanes 1–3) or GST-Emi2 (aa 489–651, lanes 4–7) immobilized on glutathione Sepharose was incubated in CSF extracts in
the presence or absence of excess recombinant Cyclin B1. The protein beads were retrieved and washed thoroughly, and the proteins were then
eluted by using glutathione. Eluted proteins were then added to an in vitro APC assay, and conversion of radiolabeled Cyclin B1 to ubiquitinated
forms was monitored by SDS-PAGE and autoradiography. (Bottom) The amount of ubiquitin conjugated Cyclin B was quantified, normalized,
and plotted (lanes 5–7). Error bars represent standard deviation of four experiments.
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219T545 and T551 to Ala, consistent with the fact that these
are the primary sites of Cdc2 phosphorylation on Emi2
(Figure 4E). Given that Emi2 phosphorylation by Cdc2/
Cyclin B caused Emi2 to dissociate from the APC, we
predicted that mutation of these sites would abrogate
this dissociation. Mutation of either T545 or T551 to
Ala partially blocked the dissociation of Emi2 from the
APC when excess Cyclin B was added to CSF extracts
(Figure 4F). However, dissociation of Emi2 from the APC
was completely inhibited by Cyclin B addition when both
T545 and T551 were mutated, suggesting that phos-
phorylation of both sites contributes to disruption of
Emi2-APC interactions (Figure 4F). In addition, the
T545/551A mutant Emi2 C terminus was a more potent
inhibitor of Cdc2/Cyclin B-induced endogenous Cyclin
B degradation than the wild-type C-terminal Emi2 in
CSF extracts (Figure 4G). Addition of the T545/551A
mutant Emi2 protein to CSF extracts also promoted in-
creased endogenous Cdc2 kinase activity, as measured
by Histone H1 phosphorylation, whereas addition of
similar amounts of wild-type Emi2 did not (Figure 4H). Fi-
nally, we repeated the experiment as in Figure 3F with
the T545/551A mutant. As shown in Figure 4I, incubating
wild-type Emi2 in a Cyclin B-treated extract caused loss
of APC inhibition and ubiquitination of Cyclin B, whereas
mutation of T545/551A prevented Emi2 inhibition and
precluded APC ubiquitination of Cyclin B. Taken to-
gether, these data argue strongly that Cdc2 sows the
seeds for Cyclin B destruction, at least in part, by phos-
phorylating the APC inhibitor Emi2 at T545 and T551.
An Okadaic-Acid-Sensitive Phosphatase Keeps
Emi2 Active to Maintain CSF Arrest
Although excess Cyclin B impeded Emi2 binding to the
APC, we were surprised to find that isolated Emi2-APC
complexes could not be fully dissociated by addition
of purified Cdc2/Cyclin B complexes (see partial disso-
ciation, Figure 5A). Although this might reflect a low
stoichiometry of phosphorylation in vitro, we speculated
that it might also indicate the presence of an Emi2-
bound phosphatase acting in opposition to Cdc2. In
this regard, it is interesting that addition of the phospha-
tase inhibitor okadaic acid (OA) to the Emi2-APC com-
plex also resulted in partial dissociation of the complex
(Figure 5A). This suggested that both an OA-sensitive
phosphatase and an Emi2-directed kinase were present
in the Emi2-APC precipitate. Interestingly, when we
added both OA and Cdc2/Cyclin B to the Emi2-APC
complexes, we achieved nearly full dissociation of the
complex (Figure 5A). Thus, inhibiting an OA-sensitive
phosphatase while enhancing Cdc2-mediated phos-
phorylation was sufficient to dissociate Emi2 from the
APC. OA did not affect Cdc2 kinase activity directly, as
shown by using recombinant Cdc2/Cyclin B1 and His-
tone H1 as an exogenous substrate (Figure 5B).
OA alone (in the absence of calcium addition) can
induce release from a CSF arrest [27] (Figure 5C). We
have also examined Cdc2 kinase activity in CSF extracts
in the presence or absence of OA to exclude the possi-
bility that OA induces CSF release and Cyclin B degra-
dation solely through enhancing the Cdc2 kinase activ-
ity. As shown in Figure 5D, OA did not measurably
affect the Histone H1-directed kinase activity in CSF
extracts. Note that Histone H1 phosphorylation wasmeasured after 10 min incubation with OA, before the
CSF extract could enter interphase (which would have
resulted in decreased Cdc2 activity).
Given the effects of OA on dissociation of the Emi2-
APC complex, we speculated that both an OA-sensitive
phosphatase and Cdc2/Cyclin B regulated the phos-
phorylation status of Emi2. Furthermore, this OA-sensi-
tive phosphatase might be required to dephosphorylate
Emi2 to maintain inhibition of the APC and CSF arrest.
To evaluate whether Emi2 was the relevant target in
OA-induced CSF release, we immobilized GST-Emi2
on glutathione-Sepharose beads and dipped the beads
into either DMSO- or OA-treated CSF extracts, with the
idea that Emi2 would become phosphorylated by en-
dogenous Cdc2/Cyclin B during the incubation if an
Emi2-directed phosphatase was inhibited by OA. The
protein beads were then retrieved by centrifugation,
washed, and added into fresh CSF extract treated with
OA to induce release. As shown in Figure 5E, the Emi2
that had been preincubated in the presence of OA was
a less potent inhibitor of Cyclin B degradation than con-
trol Emi2 protein. These data suggest that an OA-sensi-
tive phosphatase promotes activation of Emi2 as an
APC inhibitor. Moreover, OA addition to CSF extracts
resulted in an electrophoretic mobility shift in Emi2, ap-
pearing just prior to release from the CSF arrest (Fig-
ure 5F; note the subsequent downshift at 60 min in the
OA-treated sample, probably reflecting dephosphoryla-
tion of Emi2 when the extracts entered interphase). Fur-
thermore, the addition of OA neither induced degrada-
tion of Emi2 nor interfered with the calcium-induced
degradation (Figure 5F). These observations indicate
that enhancing Emi2 phosphorylation by Cdc2/Cyclin
B or inhibiting an Emi2-directed phosphatase can in-
duce dissociation of Emi2 from the APC, allowing APC
activation and exit from CSF arrest.
Emi2 Associates with PP2A, Opposing
Cdc2-Mediated Emi2 Phosphorylation
OA can inhibit both PP1 and PP2A, albeit at different con-
centrations. To determine which phosphatase was being
inhibited by OA to allow Emi2 phosphorylation and CSF
release, we performed an OA titration. As shown in Fig-
ure 6A, release from the CSF arrest occurred at a low
concentration (1 mM) of OA, a concentration that inhibits
PP2A, but not PP1, in the Xenopus egg extract [28]
(Figure 6A). We also found that PP2A, but not PP1, could
be retrieved from CSF extracts in association with GST-
Emi2 (Figure 6B). Moreover, PP2A immunoprecipitated
from CSF extracts could catalyze the in vitro dephos-
phorylation of Cdc2-phosphorylated Emi2 (Figure 6C).
These data suggest that PP2A is an Emi2-directed phos-
phatase and that inhibition of PP2A is important for
OA-induced CSF release.
Although OA synergized with Cdc2/Cyclin B to induce
release of Emi2 from the APC, it remained possible that
PP2A did not act on the Cdc2 phosphorylation sites of
Emi2. To address this, we examined the ability of OA
to promote release from the CSF arrest in the presence
of excess wild-type or T545/551A Emi2 protein. As
shown in Figure 6D, wild-type Emi2 slowed OA-induced
release from a CSF arrest, whereas the mutant Emi2 was
considerably more potent at delaying the CSF release.
Moreover, when we phosphorylated Emi2 in vitro with
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dephosphorylation of Emi2 was inhibited (data not
shown). These data demonstrate that PP2A antagonizes
the effects of Cdc2 on Emi2. However, the effects of
OA in inducing release might not have been solely due
to inhibition of T545 and T551 dephosphorylation be-
cause the double mutant was only partially resistant
to OA-induced dissociation of the Emi2-APC complex
(Figure 6E). Thus, although PP2A opposes Cdc2 in
regulating Emi2, these data suggest that another ki-
nase, in addition to Cdc2, can also regulate Emi2-APC
interactions.
Discussion
M phase exit requires APC-mediated degradation of B
type cyclins [29]. To transition sharply from M to S
phase, cells must degrade cyclins rapidly and efficiently.
Therefore, unrestrained Cyclin B accumulation during
a CSF arrest could pose a problem: If the degradative
machinery were overwhelmed by high Cyclin B levels,
M phase exit following fertilization might be gradual
rather than abrupt [30]. Interestingly, our preliminary re-
sults also indicate that excess Cyclin B may predispose
CSF-arrested eggs, which are normally quite refractory
to apoptosis, to undergo premature cell death (J.A.P.,
Q.W., and S.K., unpublished data). Therefore, eggs
that might have difficulties properly executing the first
postfertilization divisions could be eliminated. To mini-
mize these problems, eggs have developed mecha-
nisms to maintain relatively constant Cyclin B levels
during the meiotic arrest. As Cyclin B levels rise, Cdc2-
mediated phosphorylation of Emi2 suppresses its
APC-inhibitory activity, allowing the APC to degradeexcess Cyclin B. However, when Cyclin B levels drop,
dephosphorylation of Emi2 by bound PP2A predomi-
nates, restoring Emi2-mediated APC inhibition. Thus,
ambient Cyclin B levels during a CSF arrest are con-
trolled by an equilibrium between Cyclin B synthesis
and degradation, influenced directly by Emi2 (Figure 7).
Cdc2 Modulates APC Inhibition
by Emi2 during a CSF Arrest
Although it was known that Cyclin B could autoregulate
to maintain constant levels during a CSF arrest, the
mechanism was not clear [24]. That Emi2 is a relevant
target of Cdc2/Cyclin B was demonstrated in several
ways. First, Emi2 preincubated in CSF extracts treated
with excess Cyclin B lost the ability to inhibit the APC
in vitro. Importantly, this effect of preincubation was
abrogated when Cdc2 phosphorylation sites were mu-
tated. Moreover, mutant Emi2 was a more effective in-
hibitor of Cyclin B degradation and CSF exit than wild-
type Emi2, arguing that Cdc2 targets Emi2 to modulate
Cyclin B degradation during the CSF arrest. Although
APC depletion promoted endogenous Cyclin B accumu-
lation, there was also evidence that Cyclin B controls its
own translation, because Cdc2/Cyclin B kinase activity
plateaued, even in extracts unable to degrade Cyclin B.
In exploring the basis for Emi2 modulation by Cdc2,
we found that excess Cyclin B diminished Emi2-APC
interactions. This effect was abrogated by mutation of
Thr 545 and Thr 551. Additionally, the effects of Cdc2
phosphorylation were unlikely to be exerted through
overall conformational changes in the protein because
Cdc2 disrupted association of the isolated Emi2 C
terminus with the APC as readily as it dissociated full-
length Emi2-APC complexes. Mutation of the Cdc2Figure 4. Phosphorylation of Emi2 by Cdc2/Cyclin B at T545 and T551 Disrupts APC Binding and Inhibition
(A) GST-Emi2 protein (aa 489–651) was incubated in CSF extracts in the absence (top) or presence (bottom) of recombinant Cyclin B1. After
incubation, the protein was retrieved on glutathione Sepharose and resolved by SDS-PAGE, and the relevant bands were excised from the
gel, trypsin digested, and analyzed by LC/MS mass spectrometry. The mass spectra of tryptic peptides were examined, and the phosphorylated
peptide (bottom: residues 545–556, [M2+H]2+ at mass-to-charge ratio (m/z) 649.6, retention time at 7.0 min) shows a 80 Da mass increase
compared to the nonphosphorylated form (top: [M2+H]2+ at m/z 609.6, retention time at 7.8 min). Asterisks indicate tryptic peptides derived
from GST protein.
(B) The same experiment was repeated as in (A) with GST-Emi2 (aa 489–651) T545/551A protein in the presence of Cyclin B1. (Top) LC/MS-ex-
tracted ion chromatogram (EIC) at m/z 1157.6 shows that unphosphorylated mutant peptide elutes at 6.8 min. (Middle) EIC at m/z 1237.6 shows
that presumed monophosphorylated mutant peptide is not detected. (Bottom) EIC at m/z 1317.6 shows that presumed diphosphorylated mutant
peptide is not detected.
(C) GST, GST-Emi2 (aa 489–651) wild-type, or GST-Emi2 (aa 489–651) T546/551A proteins were incubated in CSF extract supplemented with
80 nM recombinant Cyclin B1 protein in the presence of [g-32P] ATP. Phosphorylation of the indicated proteins was examined by autoradiogra-
phy at 0 and 10 min.
(D) (Top) Cdc2 was depleted from CSF extracts by three consecutive incubations with recombinant His-p13 coupled to CnBr-activated Sephar-
ose. Control and Cdc2-depleted extracts were immunoblotted with Cdc2 antibody. (Bottom) GST-Emi2 (aa 489–651) wild-type protein was
incubated in the depleted extracts supplemented with 80 nM recombinant Cyclin B1 in the presence of [g-32P] ATP. The phosphorylation of
GST-Emi2 (aa 489–651) wild-type protein was examined by autoradiography at 0 and 10 min.
(E) GST, GST-Emi2 (aa 489–651) wild-type, or GST-Emi2 (aa 489–651) T546/551A proteins were incubated with [g-32P] ATP in the presence or
absence of recombinant Cdc2/Cyclin B kinase for 10 min. The reactions were separated by SDS-PAGE and the phosphorylation of the indicated
proteins was monitored by autoradiography.
(F) GST-Emi2 protein (aa 489–651; wild-type, T545/551A, T545A, or T551A) linked to glutathione Sepharose was incubated in CSF extracts in the
presence or absence of exogenous Cyclin B1. After incubation, the protein beads were retrieved by centrifugation, washed, and immunoblotted
for Cdc27 or GST.
(G) Recombinant Cyclin B1 was added into CSF extracts also supplemented with either GST, GST-Emi2 (aa 489–651) wild-type, or GST-Emi2
(aa 489–651) T545/551A proteins. At the indicated times, samples were withdrawn and immunoblotted for endogenous Cyclin B2.
(H) MBP, MBP-Emi2 (aa 489–651) wild-type, or MBP-Emi2 (aa 489–651) T545/551A proteins were added into CSF extracts. Aliquots were re-
moved at the indicated times, and the Cdc2/Cyclin B kinase activity was measured by Histone H1 kinase assays. The phosphorylation of Histone
H1 was measured, normalized, and plotted.
(I) (Top) An in vitro APC assay was performed as described in Figure 3F by using wild-type or T545/551A mutant Emi2 proteins (aa 489–651).
(Bottom) The amount of ubiquitin-conjugated Cyclin B was quantified, normalized, and plotted (lanes 2–6). Error bars represent standard
deviation of four experiments.
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(A) GST-Emi2 (FL) protein beads were incubated in CSF extracts to bind Cdc27. The beads were retrieved, washed, and then incubated in fresh
buffer containing MgCl2 and ATP in the presence of DMSO (2), okadaic acid (OA), or recombinant Cdc2/Cyclin B1 or in combination as indicated.
After incubation, the protein beads were pelleted, washed, and immunoblotted for Cdc27 and GST.
(B) Histone H1 protein was incubated with [g-32P] ATP and recombinant Cdc2/Cyclin B kinase in the presence or absence of or OA for 10 min. The
reactions were separated by SDS-PAGE, and the phosphorylation of Histone H1 was monitored by autoradiography.
(C) DMSO or 5 mM OA was added to CSF extracts. Samples were taken at the indicated times, and the endogenous Cyclin B2 levels were
examined by immunoblotting.
(D) CSF extracts were incubated with or without OA, and the Cdc2 kinase activity of the extracts was examined by using Histone H1 as a sub-
strate. The reactions were separated by SDS-PAGE, and the phosphorylation of Histone H1 was monitored by autoradiography.
(E) GST-Emi2 (FL) protein linked to glutathione Sepharose was incubated in CSF extracts supplemented with either DMSO or OA. After incuba-
tion, the protein beads were retrieved, thoroughly washed, and transferred into fresh CSF extracts supplemented with OA. Samples were taken
at the indicated times to monitor Cyclin B2 levels by immunoblotting.
(F) 35S-labeled Cyclin B1 and Emi2 proteins were synthesized in vitro and added to CSF extracts. After 15 min incubation, Ca2+, DMSO, or OA
(or both Ca2+ and OA) was added. Aliquots were removed at the indicated times, and the degradation or gel-mobility shifting of both Cyclin B1
and Emi2 were examined by autoradiography with a phosphorimager.phosphorylation sites did not prevent calcium-addition-
induced Emi2 degradation, suggesting that Cdc2 and
CaMKII regulation of Emi2 are unlinked. Indeed, Cdc2
phosphorylation did not alter Emi2 stability.
PP2A Antagonizes Cdc2 in Regulation of Emi2
Although excess Cyclin B dissociated Emi2 from the
APC in CSF extracts, purified Cdc2/Cyclin B was a
weak trigger of dissociation when the isolated in vitro
Emi2-APC complex was assayed. Although this may
have reflected a low stoichiometry of phosphorylation
in vitro, it also suggested that there might be a phospha-
tase antagonizing Cdc2 within the in vitro complex. Con-
sistent with this, addition of OA in concert with Cdc2/
Cyclin B efficiently dissociated the Emi2-APC complex.
Although OA alone can promote a release from CSF ar-
rest [21, 27], we do not believe that the sites of Cdc2
phosphorylation are the only important PP2A targetson Emi2. Additional phosphorylated peptides were de-
tected when Emi2 was analyzed by LC/MS mass spec-
trometry after incubation in OA-treated CSF extracts
(M.Z.W., Q.W., and S.K., unpublished data). Interest-
ingly, OA alone could induce a partial release of Emi2
from the coprecipitated APC in vitro. Thus, there must
have been an Emi2-directed kinase also present in the
precipitate.
Although we have seen that Emi2 can bind Cdc2 (data
not shown), it is unlikely that this is the only relevant
Emi2-directed kinase in the precipitate because we
have noted partial dissociation of Emi2-APC complexes
by OA even when mutant Emi2 lacking Cdc2 phosphor-
ylation sites was used to retrieve the APC from extracts.
It is an interesting possibility that this additional Emi2-
bound kinase(s) might be CaMKII or Plx1. Although
these kinases promote Emi2 degradation in the full CSF
extract (or intact egg), in the purified in vitro reaction,
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(A) DMSO, 1 mM OA, or 3 mM OA was added to CSF extracts. Aliquots were removed at the indicated times and immunoblotted for endogenous
Cyclin B2.
(B) GST or GST-Emi2 (FL) protein beads were incubated in CSF extracts. After incubation, the protein beads were retrieved, washed, and immu-
noblotted for PP2A (top) and PP1 (bottom).
(C) IgG or PP2A antibody was immobilized on Protein A Sepharose beads and incubated in CSF extracts. The beads were retrieved, washed, and
mixed with GST-Emi2 (aa 489–651) wild-type protein that was prephosphorylated with recombinant Cdc2/Cyclin B kinase in the presence of
[g-32P] ATP. The phosphorylation of GST-Emi2 (aa 489–651) wild-type was examined by autoradiography after 0, 30, and 60 min.
(D) OA was added into CSF extracts supplemented with GST, GST-Emi2 WT, or GST-Emi2 T545/551A proteins. At the indicated times, samples
were withdrawn and immunoblotted for endogenous Cyclin B2.
(E) GST-Emi2 protein beads (aa 489–651; wild-type or T545/551A) were incubated in CSF extracts in the presence of DMSO (2) or OA. After
incubation, the protein beads were retrieved, washed, and immunoblotted for Cdc27 and GST.absent E3 ligases or proteasomes, it may be that the
consequence of such phosphorylation is dissociation,
rather than degradation. These (or other) kinases might
Figure 7. Cyclin B Levels Are Regulated by Cdc2 and PP2A Modu-
lation Emi2 during a CSF Arrest
Cyclin B proteins are continually synthesized and degraded during
a CSF arrest. When Cyclin B levels become elevated because of on-
going synthesis, the resulting increase in Cdc2 kinase activity tilts
the balance between Cdc2/Cyclin B and PP2A, allowing for the
phosphorylation of Emi2. This promotes the dissociation of Emi2
from the APC, thus activating a proportion of APC and allowing for
some Cyclin B degradation. Degradation of Cyclin B lowers Cdc2
kinase activity, allowing PP2A to predominate, thus shifting the
balance toward dephosphorylated Emi2, which can inhibit the APC
to block further Cyclin B degradation.promote degradation of Emi2 in a two-step manner,
triggering dissociation of the Emi2-APC complex prior
to degradation. This possibility merits further investiga-
tion, as does the possibility that PP2A antagonizes Emi2
degradation. Data presented here have shown that Emi2
can be regulated directly by phosphorylation as well as
by degradation. It will be of interest to determine how
these pathways are integrated and how Emi2-directed
kinase and phosphatase activities are coordinated to
control M phase exit.
Supplemental Data
Experimental Procedures are in the Supplemental Data available
with this article online at http://www.current-biology.com/cgi/
content/full/17/3/213/DC1/.
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